These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25588161)

  • 1. N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model.
    Chang MC; Tsai ET; Wu JY; Liao HF; Chen YJ; Kuo CD
    Anticancer Drugs; 2015 Jun; 26(5):508-17. PubMed ID: 25588161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.
    Chang MC; Wu JY; Liao HF; Chen YJ; Kuo CD
    Anticancer Drugs; 2015 Nov; 26(10):1034-42. PubMed ID: 26288134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: A quantitative pilot study.
    Chang MC; Wu JY; Liao HF; Chen YJ; Kuo CD
    Medicine (Baltimore); 2016 Aug; 95(31):e4467. PubMed ID: 27495082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Jurkat T Cell Growth by
    Wu JY; Tsai ET; Yang FY; Lin JF; Liao HF; Chen YJ; Kuo CD
    Anticancer Res; 2020 May; 40(5):2675-2685. PubMed ID: 32366412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
    Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
    J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cantharidin-based small molecules as potential therapeutic agents.
    Puerto Galvis CE; Vargas Méndez LY; Kouznetsov VV
    Chem Biol Drug Des; 2013 Nov; 82(5):477-99. PubMed ID: 23809227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
    Adams EG; Bhuyan BK
    Cancer Res; 1986 Dec; 46(12 Pt 1):6125-30. PubMed ID: 2946401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
    Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
    Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
    Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenolic compounds, sodium salicylate and related compounds, as inhibitors of tumor cell growth and inducers of apoptosis in mouse leukemia L1210 cells.
    Cory AH; Cory JG
    In Vivo; 2005; 19(1):31-5. PubMed ID: 15796154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
    Yeh CB; Su CJ; Hwang JM; Chou MC
    Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
    Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
    Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of apoptosis responses in p53-deficient L1210 cells by compounds directed at blocking NFkappaB activation.
    Cory AH; Cory JG
    Anticancer Res; 2001; 21(6A):3807-11. PubMed ID: 11911251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status.
    Lee DH; Jang PS; Chung NG; Cho B; Jeong DC; Kim HK
    Exp Hematol; 2013 Jun; 41(6):539-46. PubMed ID: 23415674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Holm B; Jensen PB; Sehested M
    Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imidazoacridinones arrest cell-cycle progression in the G2 phase of L1210 cells.
    Augustin E; Wheatley DN; Lamb J; Konopa J
    Cancer Chemother Pharmacol; 1996; 38(1):39-44. PubMed ID: 8603450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.